Lilly’s Mounjaro leads to more and faster weight loss than Novo obesity drug, data analysis finds – Reuters

Lilly’s Mounjaro leads to more and faster weight loss than Novo obesity drug, data analysis finds Reuters

Brought to you by Google News. Read the rest of the article here.

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates on women's health.

You have Successfully Subscribed!